Association between uterine serous carcinoma and breast cancer

被引:38
|
作者
Gehrig, PA
Bae-Jump, VL
Boggess, JF
Groben, PA
Fowler, WC
Van Le, L
机构
[1] Univ N Carolina, Div Gynecol Oncol, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
endometrial cancer; breast cancer; tamoxifen;
D O I
10.1016/j.ygyno.2004.04.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Endometrial cancer and breast cancer are two common malignancies found in women. As a result of estrogen dependency, an association is thought to exist between these entities. This study was undertaken to determine if the endometrial carcinomas, which develop in women with a history of breast cancer, were more likely to be of the endometrioid or the serous histology, which is generally considered non-estrogen-dependent. Methods. A retrospective chart review was conducted for the years 1984-2001. All women who were diagnosed at our institution with endometrial carcinoma were identified. The women who also had a prior history of breast cancer were identified and comprise the cohort for this study. Information regarding age at diagnosis, tumor stage, histologic subtype, and tamoxifen exposure were recorded and analyzed. Results. About 1,166 women were diagnosed with endometrial cancer during the study period, of whom 54 (4.6%) had a pre-existing diagnosis of breast cancer. Of the 54 women in this study, 41 had tumors of the endometrioid histology and 13 had a tumor of the serous subtype. There was no difference with regards to median age at the time of diagnosis or years of tamoxifen exposure. Women with breast cancer were more likely to develop uterine serous carcinoma (USC) as compared to one of endometrioid histology (OR 2.6; 95% CI 1.29-5.23). Conclusions. Women with breast cancer who subsequently developed endometrial cancer exhibited a 2.6-fold increased risk of developing a USC as compared to an endometrioid carcinoma. These findings suggest that there may be an underlying genetic predisposition linking breast cancer and USC. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:208 / 211
页数:4
相关论文
共 50 条
  • [1] Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma
    Pierce, Stuart R.
    Stine, Jessica E.
    Gehrig, Paola A.
    Havrilesky, Laura J.
    Secord, Angeles A.
    Nakayama, John
    Snavely, Anna C.
    Moore, Dominic T.
    Kim, Kenneth H.
    GYNECOLOGIC ONCOLOGY, 2017, 144 (03) : 531 - 535
  • [2] Uterine serous carcinoma: assessing association between genomics and patterns of metastasis
    Alessandrino, Francesco
    Goncalves, Nicole
    Metalonis, Sarah Wishnek
    Luna, Cibele
    Mason, Matthew M.
    Lyu, Jiangnan
    Huang, Marilyn
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Uterine Papillary Serous Carcinoma
    Moore, Kathleen N.
    Fader, Amanda Nickles
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2011, 54 (02) : 278 - 291
  • [4] Aging and uterine serous carcinoma
    Hachisuga, Toru
    HISTOLOGY AND HISTOPATHOLOGY, 2018, 33 (11) : 1125 - 1133
  • [5] Uterine serous carcinoma
    Bogani, Giorgio
    Ray-Coquard, Isabelle
    Concin, Nicole
    Ngoi, Natalie Y. L.
    Morice, Philippe
    Enomoto, Takayuki
    Takehara, Kazuhiro
    Denys, Hannelore
    Nout, Remi A.
    Lorusso, Domenica
    Vaughan, Michelle M.
    Bini, Marta
    Takano, Masashi
    Provencher, Diane
    Indini, Alice
    Sagae, Satoru
    Wimberger, Pauline
    Poka, Robert
    Segev, Yakir
    Kim, Se Ik
    dos Reis, Francisco J. Candido
    Lopez, Salvatore
    Mariani, Andrea
    Leitao, Mario M., Jr.
    Raspagliesi, Francesco
    Panici, Pieluigi Benedetti
    Di Donato, Violante
    Muzii, Ludovico
    Colombo, Nicoletta
    Scambia, Giovanni
    Pignata, Sandro
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (01) : 226 - 234
  • [6] Targeted Therapies in the Treatment of Uterine Serous Carcinoma
    Tymon-Rosario, Joan R.
    Gorman, Megan
    Santin, Alessandro D.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (12) : 1804 - 1817
  • [7] Association between endometrial cancer and tamoxifen treatment of breast cancer
    Christian Peters‐Engl
    Wilhelm Frank
    Eberhard Danmayr
    Hans P. Friedl
    Sepp Leodolter
    Michael Medl
    Breast Cancer Research and Treatment, 1999, 54 : 255 - 260
  • [8] Association between endometrial cancer and tamoxifen treatment of breast cancer
    Peters-Engl, C
    Frank, W
    Danmayr, E
    Friedl, HP
    Leodolter, S
    Medl, M
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (03) : 255 - 260
  • [9] Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer
    El-Sahwi, Karim S.
    Schwartz, Peter E.
    Santin, Alessandro D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (01) : 41 - 49
  • [10] Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling - A SEER Analysis
    Nahshon, Chen
    Segev, Yakir
    Schmidt, Meirav
    Shulman, Katerina
    Lavie, Ofer
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (12) : 728 - 734